Gender differences in melanoma awareness, diagnosis and treatment: Patient‐reported data from a multicentre survey in Switzerland

Author:

Mangana Johanna12,Lamos Cristina3,Özdemir Berna C.4,Läubli Heinz5,Morgan Linda12,Maul Lara V.6,König David5,Dimitriou Florentia12,Kaiser Sandra7,Landolt Janine7,Musiari Anastasia7,Pasche Nadine7,Siegenthaler Beat7,Dummer Reinhard12,Del Prete Valerio12

Affiliation:

1. Department of Dermatology University Hospital Zurich Zurich Switzerland

2. University of Zurich UZH Zurich Switzerland

3. Department of Dermatology HFR Fribourg – Cantonal Hospital Villars‐sur‐Glâne Switzerland

4. Department of Oncology University Hospital Bern Bern Switzerland

5. Division of Medical Oncology University Hospital Basel Basel Switzerland

6. Department of Dermatology University Hospital of Basel Basel Switzerland

7. Novartis Pharma Schweiz AG Risch‐Rotkreuz Switzerland

Publisher

Wiley

Reference8 articles.

1. World Cancer Research Fund International.Skin cancer statistics;2020.https://www.wcrf.org/cancer‐trends/skin‐cancer‐statistics/. Last accessed October 2022.

2. International Agency for Research on Cancer.Population attributable fraction (PAF) of melanoma cases worldwide in 2012  among men and women of all ages (30+ years) attributable to ultraviolet (UV) radiation exposure by country;2012. https://gco.iarc.fr/causes/uv/tools-map?mode=1&sex=0&population=1&continent=0&cancer=0&key=paf&age_group=3. Last accessed 20 September 2022.

3. Cancer.org.Targeted therapy drugs for melanoma skin cancer.https://www.cancer.org/cancer/melanoma‐skin‐cancer/treating/targeted‐therapy.html#:~:text=either%20one%20alone.‐ BRAF%20inhibitors can't%20be%20removed%20completely. Last accessed December 2022.

4. Weill Cornell Medicine.Overcoming cancer: the importance of a strong support network.https://weillcornell.org/news/overcoming‐cancer‐the‐importance‐of‐a‐strong‐support‐network. Last accessed 15 September 2022.

5. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification;Rastrelli M;In Vivo,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3